Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.


CSE:IME - Post by User

Bullboard Posts
Post by Papertiger73on Jan 17, 2020 10:42am
154 Views
Post# 30564918

Where we will end up on shares after the PP

Where we will end up on shares after the PPCurrently:
 
There are 139M shares outstanding

11M options

about 28M warrants at roughly 32 cents which expire in April.

New issue is 20M shares plus 20M more in over allotment plus an equal number of warrants at 15 cents.

When the dust settles I believe we will be at 

179M shares
11M options
40M warrants at 15 cents
28M warrants at 32 cents might be 38 cents ( i think these will expire)

By end of April IME should have 220M shares, options and warrants outstanding, or if the prices rises considerably 250M shares 

There is no real point in a rollback (as they generally do not work)

The only thing to really move the stock will be FDA news.

Hopefully the $2M they raise from this issuance will last until IME receives favourable FDA news.

GLTALs 
Bullboard Posts